Capturing the variety of clinical pathways in patients with schizophrenic disorders through state sequences analysis.
Care pathways
Schizophrenic disorder
State sequence analysis
Journal
BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545
Informations de publication
Date de publication:
29 07 2023
29 07 2023
Historique:
received:
28
10
2022
accepted:
20
07
2023
medline:
31
7
2023
pubmed:
30
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Care pathways are increasingly being used to enhance the quality of care and optimize the use of resources for health care. Nevertheless, recommendations regarding the sequence of care are mostly based on consensus-based decisions as there is a lack of evidence on effective treatment sequences. In a real-world setting, classical statistical tools were insufficient to consider a phenomenon with such high variability adequately and have to be integrated with novel data mining techniques suitable for identifying patterns in complex data structures. Data-driven techniques can potentially support empirically identifying effective care sequences by extracting them from data collected routinely. The purpose of this study is to perform a state sequence analysis (SSA) to identify different patterns of treatment and to asses whether sequence analysis may be a useful tool for profiling patients according to the treatment pattern. The clinical application that motivated the study of this method concerns the mental health field. In fact, the care pathways of patients affected by severe mental disorders often do not correspond to the standards required by the guidelines in this field. In particular, we analyzed patients with schizophrenic disorders (i.e., schizophrenia, schizotypal or delusional disorders) using administrative data from 2015 to 2018 from Lombardy Region. This methodology considers the patient's therapeutic path as a conceptual unit, composed of a succession of different states, and we show how SSA can be used to describe longitudinal patient status. We define the states to be the weekly coverage of different treatments (psychiatric visits, psychosocial interventions, and anti-psychotic drugs), and we use the longest common subsequences (dis)similarity measure to compare and cluster the sequences. We obtained three different clusters with very different patterns of treatments. This kind of information, such as common patterns of care that allowed us to risk profile patients, can provide health policymakers an opportunity to plan optimum and individualized patient care by allocating appropriate resources, analyzing trends in the health status of a population, and finding the risk factors that can be leveraged to prevent the decline of mental health status at the population level.
Sections du résumé
BACKGROUND
Care pathways are increasingly being used to enhance the quality of care and optimize the use of resources for health care. Nevertheless, recommendations regarding the sequence of care are mostly based on consensus-based decisions as there is a lack of evidence on effective treatment sequences. In a real-world setting, classical statistical tools were insufficient to consider a phenomenon with such high variability adequately and have to be integrated with novel data mining techniques suitable for identifying patterns in complex data structures. Data-driven techniques can potentially support empirically identifying effective care sequences by extracting them from data collected routinely. The purpose of this study is to perform a state sequence analysis (SSA) to identify different patterns of treatment and to asses whether sequence analysis may be a useful tool for profiling patients according to the treatment pattern.
METHODS
The clinical application that motivated the study of this method concerns the mental health field. In fact, the care pathways of patients affected by severe mental disorders often do not correspond to the standards required by the guidelines in this field. In particular, we analyzed patients with schizophrenic disorders (i.e., schizophrenia, schizotypal or delusional disorders) using administrative data from 2015 to 2018 from Lombardy Region. This methodology considers the patient's therapeutic path as a conceptual unit, composed of a succession of different states, and we show how SSA can be used to describe longitudinal patient status.
RESULTS
We define the states to be the weekly coverage of different treatments (psychiatric visits, psychosocial interventions, and anti-psychotic drugs), and we use the longest common subsequences (dis)similarity measure to compare and cluster the sequences. We obtained three different clusters with very different patterns of treatments.
CONCLUSIONS
This kind of information, such as common patterns of care that allowed us to risk profile patients, can provide health policymakers an opportunity to plan optimum and individualized patient care by allocating appropriate resources, analyzing trends in the health status of a population, and finding the risk factors that can be leveraged to prevent the decline of mental health status at the population level.
Identifiants
pubmed: 37516839
doi: 10.1186/s12874-023-01993-7
pii: 10.1186/s12874-023-01993-7
pmc: PMC10386768
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
174Informations de copyright
© 2023. The Author(s).
Références
Epidemiol Psychiatr Sci. 2022 Feb 14;31:e15
pubmed: 35156603
Int Clin Psychopharmacol. 2011 Jan;26(1):54-62
pubmed: 20881845
Behav Ther. 2020 Sep;51(5):675-687
pubmed: 32800297
Stat Methods Med Res. 2019 Jun;28(6):1651-1663
pubmed: 29717944
BMJ Open. 2017 Dec 26;7(12):e019503
pubmed: 29282274
Stat Methods Med Res. 2009 Feb;18(1):7-26
pubmed: 18562396
Int J Qual Health Care. 2003 Dec;15(6):523-30
pubmed: 14660535
Br J Psychiatry Suppl. 2007 Aug;50:s37-41
pubmed: 18019042
Hypertension. 2015 Mar;65(3):490-8
pubmed: 25624339
Value Health. 2009 Sep;12(6):989-95
pubmed: 19402852
Eur J Public Health. 2018 Apr 1;28(2):214-219
pubmed: 29040495
Epidemiol Psychiatr Sci. 2017 Aug;26(4):383-394
pubmed: 27780495
Ann Ist Super Sanita. 2009;45(1):5-16
pubmed: 19567972
Stat Methods Med Res. 2010 Jun;19(3):271-89
pubmed: 19608600
Biom J. 2021 Feb;63(2):305-322
pubmed: 32869340
Stat Methods Med Res. 2019 Jun;28(6):1731-1740
pubmed: 29742976
Clin Epidemiol. 2020 Oct 30;12:1205-1222
pubmed: 33154677
Drug Saf. 2019 Mar;42(3):347-363
pubmed: 30269245
Biom J. 2014 Sep;56(5):732-53
pubmed: 24421177
Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):565-74; discussion 575-7
pubmed: 16514590
Soc Psychiatry Psychiatr Epidemiol. 2022 Mar;57(3):519-529
pubmed: 34132836
Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):476-84
pubmed: 23623808
Rev Neurol (Paris). 2016 Apr-May;172(4-5):295-306
pubmed: 27038535
Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1146-53
pubmed: 24030723
Eur J Epidemiol. 2018 Jun;33(6):545-555
pubmed: 29605890
Int J Environ Res Public Health. 2021 Dec 20;18(24):
pubmed: 34949007
Int J Qual Health Care. 2016 Dec 01;28(6):728-733
pubmed: 27578632
BMJ Open. 2015 Jun 03;5(6):e007140
pubmed: 26041489
Ann Gen Psychiatry. 2013 Oct 23;12(1):32
pubmed: 24148707